CEACAM5 and neoplasm: After correction for our MV- inflammation model (age, gender, BMI, smoking, TCL, plasma glucose, SBP, prevalent CVD and CRP), two tumour biomarkers CA15-3 and CEA (HR 2.88, 95% CI 1.58–5.24 and HR 1.87, 95% CI 1.33–2.64) remained strongly associated with CV mortality (Table 7).